Malawi

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
7.86 (6.51 - 9.33) 2019 Modelled IHME
7.86 (6.40 - 9.31) 2018 Modelled IHME
7.91 (6.33 - 9.53) 2017 Modelled IHME
8.42 (6.81 - 9.96) 2016 Modelled IHME
9.07 (7.32 - 10.75) 2015 Modelled IHME
9.36 (7.52 - 11.13) 2014 Modelled IHME
9.58 (7.71 - 11.37) 2013 Modelled IHME
9.76 (7.85 - 11.60) 2012 Modelled IHME
9.93 (7.93 - 11.90) 2011 Modelled IHME
10.12 (8.05 - 12.26) 2010 Modelled IHME
10.33 (8.24 - 12.42) 2009 Modelled IHME
10.53 (8.50 - 12.56) 2008 Modelled IHME
10.74 (8.70 - 12.79) 2007 Modelled IHME
10.95 (8.87 - 13) 2006 Modelled IHME
11.18 (9.06 - 13.25) 2005 Modelled IHME
11.46 (9.26 - 13.60) 2004 Modelled IHME
11.81 (9.47 - 14.18) 2003 Modelled IHME
12.14 (9.69 - 14.70) 2002 Modelled IHME
12.41 (9.82 - 15.19) 2001 Modelled IHME
12.56 (9.88 - 15.47) 2000 Modelled IHME
12.61 (10.03 - 15.32) 1999 Modelled IHME
12.66 (10.04 - 15.27) 1998 Modelled IHME
12.7 (10.05 - 15.31) 1997 Modelled IHME
12.72 (10.06 - 15.37) 1996 Modelled IHME
12.73 (10.04 - 15.40) 1995 Modelled IHME
12.66 (10.04 - 15.23) 1994 Modelled IHME
12.49 (9.89 - 14.96) 1993 Modelled IHME
12.23 (9.72 - 14.68) 1992 Modelled IHME
11.9 (9.40 - 14.38) 1991 Modelled IHME
11.54 (9.10 - 14.01) 1990 Modelled IHME
6.91 (5.25 - 8.88) 2015 Modelled WHO
3.2 (2.70 - 3.90) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.59 (1.17 - 2.14) 2019 Modelled IHME
1.66 (1.21 - 2.14) 2018 Modelled IHME
1.68 (1.23 - 2.19) 2017 Modelled IHME
1.64 (1.22 - 2.11) 2016 Modelled IHME
1.6 (1.17 - 2.07) 2015 Modelled IHME
1.57 (1.16 - 2.04) 2014 Modelled IHME
1.54 (1.14 - 2) 2013 Modelled IHME
1.52 (1.12 - 1.97) 2012 Modelled IHME
1.5 (1.10 - 1.94) 2011 Modelled IHME
1.5 (1.09 - 1.95) 2010 Modelled IHME
1.52 (1.10 - 1.97) 2009 Modelled IHME
1.57 (1.15 - 2.05) 2008 Modelled IHME
1.65 (1.20 - 2.16) 2007 Modelled IHME
1.76 (1.27 - 2.34) 2006 Modelled IHME
1.9 (1.35 - 2.55) 2005 Modelled IHME
2.78 (1.98 - 3.70) 2004 Modelled IHME
4.65 (3.36 - 6.14) 2003 Modelled IHME
6.84 (4.94 - 9.04) 2002 Modelled IHME
8.66 (6.27 - 11.54) 2001 Modelled IHME
9.45 (6.83 - 12.61) 2000 Modelled IHME
9.48 (6.96 - 12.64) 1999 Modelled IHME
9.5 (7.07 - 12.64) 1998 Modelled IHME
9.52 (7.09 - 12.66) 1997 Modelled IHME
9.53 (7.05 - 12.67) 1996 Modelled IHME
9.54 (6.89 - 12.71) 1995 Modelled IHME
9.48 (6.96 - 12.44) 1994 Modelled IHME
9.31 (6.86 - 12.13) 1993 Modelled IHME
9.07 (6.62 - 11.82) 1992 Modelled IHME
8.77 (6.38 - 11.47) 1991 Modelled IHME
8.43 (6.11 - 11.11) 1990 Modelled IHME
3.03 (1.92 - 4.36) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,102,870 (869,411 - 1,338,910) 1990 Modelled IHME
1,176,500 (929,293 - 1,421,040) 1991 Modelled IHME
1,234,150 (981,192 - 1,481,900) 1992 Modelled IHME
1,247,700 (988,529 - 1,494,950) 1993 Modelled IHME
1,237,600 (981,358 - 1,488,800) 1994 Modelled IHME
1,250,940 (986,566 - 1,513,760) 1995 Modelled IHME
1,281,140 (1,013,710 - 1,548,430) 1996 Modelled IHME
1,310,280 (1,037,380 - 1,580,290) 1997 Modelled IHME
1,338,460 (1,061,740 - 1,614,610) 1998 Modelled IHME
1,365,800 (1,085,950 - 1,658,800) 1999 Modelled IHME
1,392,790 (1,095,920 - 1,715,940) 2000 Modelled IHME
1,410,290 (1,115,550 - 1,725,510) 2001 Modelled IHME
1,412,430 (1,127,740 - 1,710,440) 2002 Modelled IHME
1,405,900 (1,127,210 - 1,688,320) 2003 Modelled IHME
1,398,420 (1,129,440 - 1,659,390) 2004 Modelled IHME
1,397,290 (1,132,260 - 1,656,140) 2005 Modelled IHME
1,403,110 (1,137,090 - 1,666,190) 2006 Modelled IHME
1,411,650 (1,143,660 - 1,681,000) 2007 Modelled IHME
1,422,590 (1,147,640 - 1,695,700) 2008 Modelled IHME
1,434,580 (1,144,590 - 1,724,780) 2009 Modelled IHME
1,446,100 (1,149,530 - 1,750,840) 2010 Modelled IHME
1,459,890 (1,165,080 - 1,749,340) 2011 Modelled IHME
1,476,820 (1,187,060 - 1,755,140) 2012 Modelled IHME
1,492,390 (1,200,680 - 1,771,510) 2013 Modelled IHME
1,501,560 (1,207,180 - 1,785,410) 2014 Modelled IHME
1,498,560 (1,208,830 - 1,776,700) 2015 Modelled IHME
1,431,570 (1,157,430 - 1,693,470) 2016 Modelled IHME
1,381,670 (1,107,130 - 1,664,840) 2017 Modelled IHME
1,410,920 (1,149,020 - 1,672,460) 2018 Modelled IHME
1,448,870 (1,200,080 - 1,719,880) 2019 Modelled IHME
585,000 (488,000 - 711,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.86 (2.60 - 5.40) 2019 Modelled IHME
3.9 (2.65 - 5.42) 2018 Modelled IHME
3.96 (2.69 - 5.53) 2017 Modelled IHME
3.93 (2.68 - 5.51) 2016 Modelled IHME
3.93 (2.70 - 5.56) 2015 Modelled IHME
4.17 (2.90 - 5.86) 2014 Modelled IHME
4.7 (3.28 - 6.53) 2013 Modelled IHME
5.37 (3.82 - 7.26) 2012 Modelled IHME
6.02 (4.31 - 8.05) 2011 Modelled IHME
6.44 (4.72 - 8.60) 2010 Modelled IHME
6.5 (4.73 - 8.64) 2009 Modelled IHME
6.63 (4.81 - 8.85) 2008 Modelled IHME
6.84 (4.92 - 9.11) 2007 Modelled IHME
7.09 (5.12 - 9.41) 2006 Modelled IHME
7.37 (5.32 - 9.82) 2005 Modelled IHME
7.67 (5.55 - 10.10) 2004 Modelled IHME
8 (5.81 - 10.50) 2003 Modelled IHME
8.38 (6.02 - 11.20) 2002 Modelled IHME
8.82 (6.35 - 11.80) 2001 Modelled IHME
9.26 (6.69 - 12.30) 2000 Modelled IHME
9.45 (6.83 - 12.60) 1999 Modelled IHME
9.55 (6.87 - 12.90) 1998 Modelled IHME
9.48 (6.83 - 12.80) 1997 Modelled IHME
9.5 (6.74 - 12.90) 1996 Modelled IHME
9.44 (6.67 - 12.70) 1995 Modelled IHME
9.28 (6.53 - 12.70) 1994 Modelled IHME
8.97 (6.28 - 12.30) 1993 Modelled IHME
8.82 (6.15 - 12.10) 1992 Modelled IHME
8.81 (6.16 - 12.20) 1991 Modelled IHME
8.9 (6.21 - 12.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
713 (480 - 996) 2019 Modelled IHME
701 (476 - 973) 2018 Modelled IHME
691 (470 - 966) 2017 Modelled IHME
668 (456 - 937) 2016 Modelled IHME
650 (446 - 919) 2015 Modelled IHME
669 (465 - 941) 2014 Modelled IHME
732 (512 - 1,018) 2013 Modelled IHME
812 (577 - 1,099) 2012 Modelled IHME
885 (633 - 1,183) 2011 Modelled IHME
920 (674 - 1,229) 2010 Modelled IHME
903 (657 - 1,199) 2009 Modelled IHME
895 (650 - 1,195) 2008 Modelled IHME
899 (647 - 1,197) 2007 Modelled IHME
908 (655 - 1,205) 2006 Modelled IHME
922 (665 - 1,228) 2005 Modelled IHME
936 (677 - 1,236) 2004 Modelled IHME
952 (692 - 1,254) 2003 Modelled IHME
975 (701 - 1,306) 2002 Modelled IHME
1,002 (721 - 1,344) 2001 Modelled IHME
1,027 (742 - 1,360) 2000 Modelled IHME
1,024 (740 - 1,360) 1999 Modelled IHME
1,010 (726 - 1,366) 1998 Modelled IHME
979 (705 - 1,322) 1997 Modelled IHME
957 (679 - 1,301) 1996 Modelled IHME
928 (656 - 1,252) 1995 Modelled IHME
907 (638 - 1,242) 1994 Modelled IHME
896 (628 - 1,228) 1993 Modelled IHME
890 (621 - 1,220) 1992 Modelled IHME
871 (609 - 1,205) 1991 Modelled IHME
850 (593 - 1,170) 1990 Modelled IHME
687 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
25 (19 - 33) 2019 Modelled IHME
25 (19 - 33) 2018 Modelled IHME
25 (19 - 33) 2017 Modelled IHME
25 (19 - 32) 2016 Modelled IHME
24 (18 - 32) 2015 Modelled IHME
24 (18 - 32) 2014 Modelled IHME
25 (19 - 32) 2013 Modelled IHME
25 (19 - 32) 2012 Modelled IHME
25 (19 - 32) 2011 Modelled IHME
26 (19 - 33) 2010 Modelled IHME
26 (20 - 33) 2009 Modelled IHME
26 (20 - 33) 2008 Modelled IHME
26 (20 - 33) 2007 Modelled IHME
26 (20 - 34) 2006 Modelled IHME
27 (21 - 34) 2005 Modelled IHME
27 (21 - 34) 2004 Modelled IHME
27 (21 - 35) 2003 Modelled IHME
28 (21 - 35) 2002 Modelled IHME
28 (21 - 36) 2001 Modelled IHME
28 (22 - 37) 2000 Modelled IHME
29 (22 - 38) 1999 Modelled IHME
30 (23 - 39) 1998 Modelled IHME
30 (23 - 40) 1997 Modelled IHME
31 (23 - 40) 1996 Modelled IHME
30 (22 - 39) 1995 Modelled IHME
29 (21 - 39) 1994 Modelled IHME
28 (20 - 38) 1993 Modelled IHME
28 (19 - 37) 1992 Modelled IHME
27 (19 - 36) 1991 Modelled IHME
26 (18 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
92 2018 Survey/reported WHO/UNICEF
88 2017 Survey/reported WHO/UNICEF
84 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
91 2014 Survey/reported WHO/UNICEF
89 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
93 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
91 2008 Survey/reported WHO/UNICEF
87 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
93 2005 Survey/reported WHO/UNICEF
89 2004 Survey/reported WHO/UNICEF
84 2003 Survey/reported WHO/UNICEF
64 2002 Survey/reported WHO/UNICEF
95 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.61 (1.29 - 2) 2019 Modelled IHME
1.6 (1.28 - 2.01) 2018 Modelled IHME
1.6 (1.27 - 2) 2017 Modelled IHME
1.6 (1.28 - 2) 2016 Modelled IHME
1.6 (1.27 - 2) 2015 Modelled IHME
1.6 (1.27 - 2) 2014 Modelled IHME
1.62 (1.29 - 2.02) 2013 Modelled IHME
1.63 (1.31 - 2.04) 2012 Modelled IHME
1.65 (1.32 - 2.07) 2011 Modelled IHME
1.67 (1.33 - 2.09) 2010 Modelled IHME
1.7 (1.35 - 2.13) 2009 Modelled IHME
1.73 (1.38 - 2.16) 2008 Modelled IHME
1.76 (1.41 - 2.20) 2007 Modelled IHME
1.78 (1.42 - 2.23) 2006 Modelled IHME
1.81 (1.44 - 2.26) 2005 Modelled IHME
1.83 (1.47 - 2.29) 2004 Modelled IHME
1.85 (1.48 - 2.31) 2003 Modelled IHME
1.86 (1.50 - 2.32) 2002 Modelled IHME
1.88 (1.52 - 2.34) 2001 Modelled IHME
1.89 (1.53 - 2.36) 2000 Modelled IHME
1.91 (1.54 - 2.38) 1999 Modelled IHME
1.93 (1.56 - 2.38) 1998 Modelled IHME
1.95 (1.58 - 2.42) 1997 Modelled IHME
1.96 (1.58 - 2.43) 1996 Modelled IHME
1.96 (1.58 - 2.44) 1995 Modelled IHME
1.96 (1.59 - 2.44) 1994 Modelled IHME
1.96 (1.59 - 2.44) 1993 Modelled IHME
1.96 (1.58 - 2.44) 1992 Modelled IHME
1.96 (1.58 - 2.43) 1991 Modelled IHME
1.96 (1.56 - 2.43) 1990 Modelled IHME
Showing out of
Show more
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
5.7 (3.60 - 8.90) 2005 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
0 (0 - 1.70) 2014 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Showing out of
Show more
Pregnant women living with HIV
Download
Value (%) Year Type Source
12 (5.60 - 23.80) 1994 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
7.3 (0 - 24.30) 2018 Modelled Epidemiology of hepatitis B, C and D in Malawi: systematic review
People living with HIV (PLHIV)
Download
Value (%) Year Type Source
0.5 (0.10 - 1.90) 2015 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
10 (7 - 14.10) 1998 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
2.2 (0.90 - 5.10) 2014 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Showing out of
Show more
Pregnant women living with HIV
Download
Value (%) Year Type Source
0.7 (0.10 - 3.90) 2001 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
2.6 (1.30 - 5) 2008 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
0.3 (0.10 - 1.80) 2008 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
5.4 (2.80 - 10.30) 2002 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
2.9 (0.80 - 9.80) 1992 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
18 (11.70 - 26.70) 1994 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
5.8 (3 - 11) 2006 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
0 (0 - 2.30) 2007 Survey/reported Epidemiology of hepatitis B, C and D in Malawi: systematic review
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
186,883 (148,976 - 232,439) 1990 Modelled IHME
193,690 (155,884 - 240,129) 1991 Modelled IHME
198,047 (159,837 - 245,886) 1992 Modelled IHME
196,155 (158,984 - 244,160) 1993 Modelled IHME
191,913 (155,238 - 238,534) 1994 Modelled IHME
192,978 (155,584 - 239,496) 1995 Modelled IHME
197,228 (159,635 - 244,280) 1996 Modelled IHME
200,762 (162,653 - 249,258) 1997 Modelled IHME
203,842 (164,588 - 251,991) 1998 Modelled IHME
206,761 (166,946 - 257,399) 1999 Modelled IHME
209,895 (169,277 - 262,130) 2000 Modelled IHME
213,266 (172,498 - 265,929) 2001 Modelled IHME
216,555 (174,504 - 269,523) 2002 Modelled IHME
219,765 (176,540 - 274,700) 2003 Modelled IHME
222,961 (179,501 - 279,250) 2004 Modelled IHME
226,033 (179,790 - 282,377) 2005 Modelled IHME
228,616 (182,059 - 285,543) 2006 Modelled IHME
230,810 (184,915 - 288,701) 2007 Modelled IHME
233,064 (186,668 - 291,509) 2008 Modelled IHME
235,714 (188,008 - 295,331) 2009 Modelled IHME
239,134 (190,024 - 298,637) 2010 Modelled IHME
243,054 (194,135 - 304,057) 2011 Modelled IHME
247,120 (197,833 - 309,217) 2012 Modelled IHME
251,670 (200,391 - 314,996) 2013 Modelled IHME
257,088 (204,474 - 320,675) 2014 Modelled IHME
263,774 (210,528 - 330,505) 2015 Modelled IHME
271,525 (217,111 - 339,345) 2016 Modelled IHME
279,512 (222,828 - 349,528) 2017 Modelled IHME
287,710 (230,579 - 360,255) 2018 Modelled IHME
296,392 (237,156 - 369,415) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.6 (5.47 - 10.10) 2019 Modelled IHME
7.64 (5.54 - 10.10) 2018 Modelled IHME
7.71 (5.66 - 10.20) 2017 Modelled IHME
7.6 (5.60 - 9.92) 2016 Modelled IHME
7.56 (5.58 - 9.92) 2015 Modelled IHME
7.56 (5.62 - 9.92) 2014 Modelled IHME
7.57 (5.63 - 9.88) 2013 Modelled IHME
7.65 (5.76 - 9.93) 2012 Modelled IHME
7.84 (5.97 - 10.20) 2011 Modelled IHME
8.11 (6.22 - 10.40) 2010 Modelled IHME
8.2 (6.26 - 10.60) 2009 Modelled IHME
8.37 (6.43 - 10.80) 2008 Modelled IHME
8.65 (6.56 - 11.10) 2007 Modelled IHME
8.96 (6.78 - 11.50) 2006 Modelled IHME
9.29 (6.94 - 11.90) 2005 Modelled IHME
9.57 (7.23 - 12.40) 2004 Modelled IHME
9.75 (7.40 - 12.70) 2003 Modelled IHME
9.94 (7.61 - 12.90) 2002 Modelled IHME
10.1 (7.75 - 13.30) 2001 Modelled IHME
10.5 (7.96 - 13.60) 2000 Modelled IHME
10.7 (8 - 13.90) 1999 Modelled IHME
10.8 (8.11 - 14) 1998 Modelled IHME
10.7 (8.12 - 13.80) 1997 Modelled IHME
10.7 (8.11 - 13.80) 1996 Modelled IHME
10.7 (7.99 - 13.80) 1995 Modelled IHME
10.5 (7.75 - 13.60) 1994 Modelled IHME
10.2 (7.42 - 13.10) 1993 Modelled IHME
9.96 (7.30 - 12.90) 1992 Modelled IHME
9.93 (7.24 - 12.80) 1991 Modelled IHME
10 (7.39 - 12.90) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,402 (1,008 - 1,854) 2019 Modelled IHME
1,371 (994 - 1,817) 2018 Modelled IHME
1,348 (989 - 1,785) 2017 Modelled IHME
1,292 (952 - 1,687) 2016 Modelled IHME
1,250 (922 - 1,639) 2015 Modelled IHME
1,213 (901 - 1,592) 2014 Modelled IHME
1,179 (877 - 1,540) 2013 Modelled IHME
1,158 (871 - 1,502) 2012 Modelled IHME
1,152 (877 - 1,492) 2011 Modelled IHME
1,158 (888 - 1,487) 2010 Modelled IHME
1,138 (870 - 1,468) 2009 Modelled IHME
1,131 (869 - 1,461) 2008 Modelled IHME
1,137 (863 - 1,461) 2007 Modelled IHME
1,148 (869 - 1,474) 2006 Modelled IHME
1,161 (867 - 1,490) 2005 Modelled IHME
1,167 (882 - 1,513) 2004 Modelled IHME
1,161 (881 - 1,508) 2003 Modelled IHME
1,156 (885 - 1,498) 2002 Modelled IHME
1,153 (880 - 1,506) 2001 Modelled IHME
1,163 (883 - 1,511) 2000 Modelled IHME
1,156 (866 - 1,506) 1999 Modelled IHME
1,141 (858 - 1,485) 1998 Modelled IHME
1,106 (838 - 1,427) 1997 Modelled IHME
1,080 (817 - 1,392) 1996 Modelled IHME
1,052 (785 - 1,361) 1995 Modelled IHME
1,030 (757 - 1,332) 1994 Modelled IHME
1,015 (741 - 1,313) 1993 Modelled IHME
1,005 (737 - 1,303) 1992 Modelled IHME
982 (715 - 1,266) 1991 Modelled IHME
956 (707 - 1,235) 1990 Modelled IHME
445 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
19 (13 - 25) 2019 Modelled IHME
19 (13 - 25) 2018 Modelled IHME
19 (13 - 25) 2017 Modelled IHME
18 (13 - 24) 2016 Modelled IHME
18 (12 - 24) 2015 Modelled IHME
18 (12 - 24) 2014 Modelled IHME
17 (12 - 23) 2013 Modelled IHME
17 (12 - 23) 2012 Modelled IHME
17 (12 - 23) 2011 Modelled IHME
17 (12 - 23) 2010 Modelled IHME
17 (12 - 23) 2009 Modelled IHME
17 (12 - 23) 2008 Modelled IHME
17 (12 - 23) 2007 Modelled IHME
17 (12 - 23) 2006 Modelled IHME
17 (12 - 23) 2005 Modelled IHME
17 (11 - 23) 2004 Modelled IHME
16 (11 - 22) 2003 Modelled IHME
16 (11 - 22) 2002 Modelled IHME
16 (11 - 22) 2001 Modelled IHME
16 (11 - 22) 2000 Modelled IHME
16 (11 - 22) 1999 Modelled IHME
17 (11 - 23) 1998 Modelled IHME
17 (11 - 23) 1997 Modelled IHME
17 (11 - 23) 1996 Modelled IHME
17 (11 - 23) 1995 Modelled IHME
17 (11 - 23) 1994 Modelled IHME
16 (11 - 23) 1993 Modelled IHME
16 (11 - 23) 1992 Modelled IHME
16 (11 - 23) 1991 Modelled IHME
16 (11 - 23) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
713
2019
(480 - 996)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,402
2019
(1,008 - 1,854)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines